Magenta Therapeutics Share Price Today
(NASDAQ: DNTH)

Name: Magenta Therapeutics Share Price Today (NASDAQ: DNTH) - Magenta Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Magenta Therapeutics share price is $22.77 & ₹1,980.28 as on 6 Mar 2025, 2.30 'hrs' IST

$22.77

▲

2.91

(14.65%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Magenta Therapeutics share price in Dollar and Rupees. Guide to invest in Magenta Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Magenta Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Magenta Therapeutics share price movements

Today's Low: $20.35
Today's High: $23.06
$22.77
10.65%
Downside
Day's Volatility :11.75%
Upside
1.24%
52 Weeks Low: $18.35
52 Weeks High: $33.77
$22.77
19.43%
Downside
52 Weeks Volatility :45.68%
Upside
32.57%

Magenta Therapeutics (DNTH) Returns

Period	Magenta Therapeutics Inc	Index (Russel 2000)
3 Months	-16.06%	0.0%
6 Months	-29.02%	0.0%
1 Year	-20.53%	0.0%
3 Years	678.82%	-11.6%

Magenta Therapeutics (DNTH) Key Statistics

in dollars & INR

Previous Close	$19.86
Open	$19.79
Today's High	$23.055
Today's Low	$20.345
Market Capitalization	$580.7M
Today's Volume	$78.8K
52 Week High	$33.77
52 Week Low	$18.345
Revenue TTM	$5.4M
EBITDA	$-82.8M
Earnings Per Share (EPS)	$7.22
PE Ratio	2.72
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-25.99%

How to invest in Magenta Therapeutics Stock (DNTH) from India?

It is very easy for Indian residents to invest directly in Magenta Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Magenta Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Magenta Therapeutics or DNTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Magenta Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Magenta Therapeutics shares which would translate to 0.038 fractional shares of Magenta Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Magenta Therapeutics, in just a few clicks!

Returns in Magenta Therapeutics (DNTH) for Indian investors in Rupees

The Magenta Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Magenta Therapeutics investment value today

Current value as on today

₹96,079

Returns

₹3,921

(-3.92%)

Returns from Magenta Therapeutics Stock

₹8,884 (-8.88%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Magenta Therapeutics (DNTH)

250%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Magenta Therapeutics Stock from India on INDmoney has increased by 250% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Magenta Therapeutics

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Magenta Therapeutics(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Magenta Therapeutics Stock (DNTH)

What analysts predicted

Upside of 131.01%

Target:

$52.60

Current:

$22.77

Insights on Magenta Therapeutics Stock (Ticker Symbol: DNTH)

Price Movement
In the last 3 years, DNTH stock has moved up by 675.8%
Increasing Revenue
Revenue is up for the last 4 quarters, 457.0K → 2.17M (in $), with an average increase of 38.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -10.56M → -25.17M (in $), with an average decrease of 33.7% per quarter
DNTH vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 82.2%
Price to Sales
ForDNTH every $1 of sales, investors are willing to pay $104.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

DNTH Magenta Therapeutics Financials in INR & Dollars

	FY21	Y/Y Change
Revenue	$1.5M	-
Net Income	$-13.1M	↓ 82.51%
Net Profit Margin	-888.14%	-

	FY22	Y/Y Change
Revenue	$6.4M	↑ 334.76%
Net Income	$-28.5M	↑ 117.22%
Net Profit Margin	-443.76%	↑ 444.38%

	FY23	Y/Y Change
Revenue	$2.8M	↓ 55.96%
Net Income	$-43.6M	↑ 52.95%
Net Profit Margin	-1.5K%	↓ 1097.46%

	Q2 FY23	Q/Q Change
Revenue	$969.0K	↑ 103.57%
Net Income	$-3.3M	↓ 88.74%
Net Profit Margin	-338.91%	↑ 5789.24%

	Q3 FY23	Q/Q Change
Revenue	$924.0K	↓ 4.64%
Net Income	$-14.8M	↑ 349.54%
Net Profit Margin	-1.6K%	↓ 1258.82%

	Q4 FY23	Q/Q Change
Revenue	$457.0K	↓ 50.54%
Net Income	$-10.6M	↓ 28.45%
Net Profit Margin	-2.3K%	↓ 713.65%

	Q1 FY24	Q/Q Change
Revenue	$874.0K	↑ 91.25%
Net Income	$-13.7M	↑ 30.15%
Net Profit Margin	-1.6K%	↑ 738.38%

	Q2 FY24	Q/Q Change
Revenue	$1.9M	↑ 113.16%
Net Income	$-17.6M	↑ 28.07%
Net Profit Margin	-945.09%	↑ 627.91%

	Q3 FY24	Q/Q Change
Revenue	$2.2M	↑ 16.59%
Net Income	$-25.2M	↑ 42.98%
Net Profit Margin	-1.2K%	↓ 213.93%

	FY18	Y/Y Change
Profit	$-875.0K	↑ 132.71%

	FY19	Y/Y Change
Profit	$-1.8M	↑ 110.63%

	FY20	Y/Y Change
Profit	$-2.0M	↑ 7.33%

	FY21	Y/Y Change
Profit	$-544.0K	↓ 72.5%

	FY22	Y/Y Change
Profit	$6.3M	↓ 1252.57%

	FY23	Y/Y Change
Profit	$2.5M	↓ 60.59%

	Q2 FY23	Q/Q Change
Profit	$969.0K	↓ 232.56%

	Q3 FY23	Q/Q Change
Profit	$905.0K	↓ 6.6%

	Q4 FY23	Q/Q Change
Profit	$354.0K	↓ 60.88%

	Q1 FY24	Q/Q Change
Profit	$767.0K	↑ 116.67%

	Q2 FY24	Q/Q Change
Profit	$1.8M	↑ 128.42%

	Q3 FY24	Q/Q Change
Profit	$2.2M	↑ 23.97%

	FY21	Y/Y Change
Operating Cash Flow	$-9.9M	↓ 84.53%
Investing Cash Flow	$-33.0K	-
Financing Cash Flow	$14.9M	↓ 77.99%

	FY22	Y/Y Change
Operating Cash Flow	$-29.1M	↑ 193.52%
Investing Cash Flow	$-59.8M	↑ 181169.7%
Financing Cash Flow	$96.7M	↑ 548.31%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-6.5M	↓ 67.21%
Investing Cash Flow	$21.9M	↑ 20.59%
Financing Cash Flow	$0.0	↓ 100.0%

Magenta Therapeutics Technicals Summary

Sell

Neutral

Buy

Magenta Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Magenta Therapeutics (DNTH) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Magenta Therapeutics Inc	-10.01%	-29.02%	-20.53%	678.82%	88.6%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Magenta Therapeutics Inc	2.72	2.72	NA	-2.27	-0.26	-0.19	NA	11.51
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Magenta Therapeutics Inc	Buy	$580.7M	88.6%	2.72	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Magenta Therapeutics

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases. It is developing DNTH103, a monoclonal antibody, which is in Phase 2 clinical trial, for the treatment of generalized myasthenia gravis, multifocal motor neuropathy, and chronic inflammatory demyelinating polyneuropathy. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Organization	Magenta Therapeutics
Employees	53
CEO	Mr. Marino Garcia M.B.A.
Industry	Miscellaneous

Management People of Magenta Therapeutics

Name	Title
Mr. Marino Garcia M.B.A.	President, CEO & Director
Mr. Ryan Savitz	Chief Financial Officer & Chief Business Officer
Mr. Simrat Randhawa M.B.A., M.D.	Chief Medical Officer
Mr. Edward G. Carr	Chief Accounting Officer
Mr. Judson Taylor	Senior VP & Head of Technical Operations
Dr. Jeffrey Stavenhagen Ph.D.	Chief Scientific Officer
Ms. Jennifer Davis Ruff	VP and Head of Investor Relations & Corporate Affairs.
Mr. Adam M. Veness Esq.	Senior VP, General Counsel & Secretary
Ms. Kristina Maximenko	Chief People Officer
Ms. Rashieda Gluck	Head of Clinical Development Operations

Important FAQs about investing in DNTH Stock from India :

What is Magenta Therapeutics share price today?

Magenta Therapeutics share price today stands at $22.77, Open: $19.79 ; Previous Close: $19.86 ; High: $23.06 ; Low: $20.35 ; 52 Week High: $33.77 ; 52 Week Low: $18.35.

The stock opens at $19.79, after a previous close of $19.86. The stock reached a daily high of $23.06 and a low of $20.35, with a 52-week high of $33.77 and a 52-week low of $18.35.

Can Indians buy Magenta Therapeutics shares?

Yes, Indians can invest in the Magenta Therapeutics (DNTH) from India.

With INDmoney, you can buy Magenta Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Magenta Therapeutics at zero transaction cost.

How can I buy Magenta Therapeutics shares from India?

It is very easy to buy Magenta Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Magenta Therapeutics (DNTH) be purchased?

Yes, you can buy fractional shares of Magenta Therapeutics with INDmoney app.

What are the documents required to start investing in Magenta Therapeutics stocks?

To start investing in Magenta Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.